{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:29:37Z","timestamp":1791318577793,"version":"4.3.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jprot.2014.11.005","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T23:11:02Z","timestamp":1416525062000},"page":"125-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins"],"prefix":"10.1016","volume":"114","author":[{"given":"Francesco","family":"Finamore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliciano","family":"Priego-Capote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Nolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Zufferey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jprot.2014.11.005_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000358728","article-title":"Diabetic neuropathies: diagnosis and management","volume":"98","author":"Deli","year":"2013","journal-title":"Neuroendocrinology"},{"issue":"2 Suppl. 2","key":"10.1016\/j.jprot.2014.11.005_bb0010","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1053\/j.ajkd.2013.10.047","article-title":"New insights into molecular mechanisms of diabetic kidney disease","volume":"63","author":"Badal","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jprot.2014.11.005_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.preteyeres.2014.03.003","article-title":"Phenotypes and biomarkers of diabetic retinopathy","volume":"41","author":"Cunha-Vaz","year":"2014","journal-title":"Prog Retin Eye Res"},{"issue":"31","key":"10.1016\/j.jprot.2014.11.005_bb0020","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I","volume":"34","author":"Paneni","year":"2013","journal-title":"Eur Heart J"},{"issue":"31","key":"10.1016\/j.jprot.2014.11.005_bb0025","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1093\/eurheartj\/eht142","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II","volume":"34","author":"Beckman","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jprot.2014.11.005_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0168-8227(94)01061-4","article-title":"Role of advanced glycation end-products (AGE) in late diabetic complications","volume":"28","author":"Sensi","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"issue":"1\u20132","key":"10.1016\/j.jprot.2014.11.005_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11010-010-0434-5","article-title":"Trends in advanced glycation end products research in diabetes mellitus and its complications","volume":"341","author":"Mendez","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jprot.2014.11.005_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/rp.56.1.1","article-title":"Protein glycation, diabetes, and aging","volume":"56","author":"Ulrich","year":"2001","journal-title":"Recent Prog Horm Res"},{"issue":"1","key":"10.1016\/j.jprot.2014.11.005_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced glycation end products and diabetic complications","volume":"18","author":"Singh","year":"2014","journal-title":"Korean J Physiol Pharmacol"},{"issue":"9","key":"10.1016\/j.jprot.2014.11.005_bb0050","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.biochi.2012.05.017","article-title":"Impaired drug-binding capacities of in vitro and in vivo glycated albumin","volume":"94","author":"Baraka-Vidot","year":"2012","journal-title":"Biochimie"},{"issue":"23\u201324","key":"10.1016\/j.jprot.2014.11.005_bb0055","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.cca.2011.07.022","article-title":"Moderate glycation of serum albumin affects folding, stability, and ligand binding","volume":"412","author":"Vetter","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.jprot.2014.11.005_bb0060","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1016\/j.bbagen.2013.01.019","article-title":"New insights into deleterious impacts of in vivo glycation on albumin antioxidant activities","volume":"1830","author":"Baraka-Vidot","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.jprot.2014.11.005_bb0065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biochi.2010.12.003","article-title":"The glycation of albumin: structural and functional impacts","volume":"93","author":"Rondeau","year":"2011","journal-title":"Biochimie"},{"issue":"21","key":"10.1016\/j.jprot.2014.11.005_bb0070","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.3760\/cma.j.issn.0366-6999.20131149","article-title":"Glycation of high-density lipoprotein in type 2 diabetes mellitus","volume":"126","author":"Sun","year":"2013","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.jprot.2014.11.005_bb0075","first-page":"15","article-title":"Glucose, glycotoxins, and protein glycation products: the role in pathogenesis","volume":"91","author":"Titov","year":"2013","journal-title":"Klin Med (Mosk)"},{"key":"10.1016\/j.jprot.2014.11.005_bb0080","doi-asserted-by":"crossref","first-page":"804","DOI":"10.5604\/17322693.1016359","article-title":"Glycation of extracellular matrix proteins and its role in atherosclerosis","volume":"66","author":"Kuzan","year":"2012","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"3","key":"10.1016\/j.jprot.2014.11.005_bb0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbrc.2009.12.179","article-title":"Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence","volume":"392","author":"Park","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.jprot.2014.11.005_bb0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","article-title":"Role of advanced glycation end products in cardiovascular disease","volume":"4","author":"Hegab","year":"2012","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jprot.2014.11.005_bb0095","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1038\/cddis.2013.180","article-title":"Glycation exacerbates the neuronal toxicity of beta-amyloid","volume":"4","author":"Li","year":"2013","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.jprot.2014.11.005_bb0100","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bbapap.2012.12.001","article-title":"Insights into the molecular mechanism of protein native-like aggregation upon glycation","volume":"1834","author":"Oliveira","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.jprot.2014.11.005_bb0105","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.bbapap.2006.08.001","article-title":"Protection against glycation and similar post-translational modifications of proteins","volume":"1764","author":"Harding","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.jprot.2014.11.005_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11596-013-1063-5","article-title":"A meta-analysis of salicylates for type 2 diabetes mellitus","volume":"33","author":"Fang","year":"2013","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"10","key":"10.1016\/j.jprot.2014.11.005_bb0115","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","article-title":"Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes","volume":"109","author":"Hundal","year":"2002","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jprot.2014.11.005_bb0120","first-page":"1120","article-title":"Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo","volume":"30","author":"Swamy","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jprot.2014.11.005_bb0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbadis.2012.08.015","article-title":"The combined effect of acetylation and glycation on the chaperone and anti-apoptotic functions of human alpha-crystallin","volume":"1832","author":"Nahomi","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.jprot.2014.11.005_bb0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0968-4328(00)00032-9","article-title":"Collagen as a model system to investigate the use of aspirin as an inhibitor of protein glycation and crosslinking","volume":"32","author":"Hadley","year":"2001","journal-title":"Micron"},{"issue":"2","key":"10.1016\/j.jprot.2014.11.005_bb0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.diabres.2006.12.024","article-title":"Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen","volume":"77","author":"Urios","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.jprot.2014.11.005_bb0140","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jb\/mvm096","article-title":"Consequential alterations in haemoglobin structure upon glycation with fructose: prevention by acetylsalicylic acid","volume":"141","author":"Bakhti","year":"2007","journal-title":"J Biochem"},{"issue":"2","key":"10.1016\/j.jprot.2014.11.005_bb0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2012.03.154","article-title":"Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study","volume":"421","author":"Svensson","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"24","key":"10.1016\/j.jprot.2014.11.005_bb0150","first-page":"3055","article-title":"Effect of aspirin on high glucose-induced senescence of endothelial cells","volume":"122","author":"Yi","year":"2009","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10.1016\/j.jprot.2014.11.005_bb0155","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.2337\/db12-0040","article-title":"High glucose inhibits the aspirin-induced activation of the nitric oxide\/cGMP\/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets","volume":"61","author":"Russo","year":"2012","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jprot.2014.11.005_bb0160","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1210\/jc.2009-2392","article-title":"Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus","volume":"95","author":"Ertugrul","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jprot.2014.11.005_bb0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.euprot.2014.02.001","article-title":"Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: an in vitro study","volume":"3","author":"Finamore","year":"2014","journal-title":"EuPA Open Proteomics"},{"issue":"2","key":"10.1016\/j.jprot.2014.11.005_bb0170","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0003-2697(82)90056-2","article-title":"Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to a positively charged membrane filter","volume":"124","author":"Gershoni","year":"1982","journal-title":"Anal Biochem"},{"issue":"2","key":"10.1016\/j.jprot.2014.11.005_bb0175","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1021\/pr4000398","article-title":"Quantitative analysis of glycated proteins","volume":"13","author":"Priego-Capote","year":"2014","journal-title":"J Proteome Res"},{"issue":"24","key":"10.1016\/j.jprot.2014.11.005_bb0180","doi-asserted-by":"crossref","first-page":"9822","DOI":"10.1021\/ac801704j","article-title":"Improved methods for the enrichment and analysis of glycated peptides","volume":"80","author":"Zhang","year":"2008","journal-title":"Anal Chem"},{"key":"10.1016\/j.jprot.2014.11.005_bb0185","first-page":"146","article-title":"EasyProt \u2014 an easy-to-use graphical platform for proteomics data analysis","volume":"79C","author":"Gluck","year":"2012","journal-title":"J Proteomics"},{"issue":"12","key":"10.1016\/j.jprot.2014.11.005_bb0190","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1096\/fj.06-5987com","article-title":"Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism","volume":"20","author":"Borthwick","year":"2006","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.jprot.2014.11.005_bb0195","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2165\/00003088-198510020-00004","article-title":"Clinical pharmacokinetics of the salicylates","volume":"10","author":"Needs","year":"1985","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"10.1016\/j.jprot.2014.11.005_bb0200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nmeth1060","article-title":"Higher-energy C-trap dissociation for peptide modification analysis","volume":"4","author":"Olsen","year":"2007","journal-title":"Nat Methods"},{"issue":"5","key":"10.1016\/j.jprot.2014.11.005_bb0205","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bcp.2009.10.007","article-title":"Reaction of human albumin with aspirin in vitro: mass spectrometric identification of acetylated lysines 199, 402, 519, and 545","volume":"79","author":"Liyasova","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.jprot.2014.11.005_bb0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2007.04.001","article-title":"Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin","volume":"382","author":"Kisugi","year":"2007","journal-title":"Clin Chim Acta"},{"issue":"25\u201326","key":"10.1016\/j.jprot.2014.11.005_bb0215","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.lfs.2012.05.002","article-title":"Immunological studies on glycated human IgG","volume":"90","author":"Ahmad","year":"2012","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.jprot.2014.11.005_bb0220","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ab.2011.06.024","article-title":"Characterization of glycation in an IgG1 by capillary electrophoresis sodium dodecyl sulfate and mass spectrometry","volume":"417","author":"Kaschak","year":"2011","journal-title":"Anal Biochem"},{"issue":"4","key":"10.1016\/j.jprot.2014.11.005_bb0225","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/ATVBAHA.109.201715","article-title":"Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I","volume":"30","author":"Nobecourt","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jprot.2014.11.005_bb0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1196\/annals.1433.005","article-title":"Nonenzymatically glycated lipoprotein ApoA-I in plasma of diabetic and nephropathic patients","volume":"1126","author":"Lapolla","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.jprot.2014.11.005_bb0235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jcla.21591","article-title":"Semiquantitative analysis of apolipoprotein A-I modified by advanced glycation end products in diabetes mellitus","volume":"27","author":"Kurosaki","year":"2013","journal-title":"J Clin Lab Anal"},{"issue":"11","key":"10.1016\/j.jprot.2014.11.005_bb0240","first-page":"749","article-title":"Application of the time-resolved immunofluorometric assay to the study of C3 complement component glycation in vitro and in vivo","volume":"31","author":"Gaillard","year":"1993","journal-title":"Eur J Clin Chem Clin Biochem"},{"issue":"12","key":"10.1016\/j.jprot.2014.11.005_bb0245","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/clinchem\/33.12.2220","article-title":"Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients","volume":"33","author":"Austin","year":"1987","journal-title":"Clin Chem"}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187439191400520X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187439191400520X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T06:08:05Z","timestamp":1717567685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187439191400520X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":49,"alternative-id":["S187439191400520X"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2014.11.005","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins","name":"articletitle","label":"Article Title"},{"value":"Journal of Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jprot.2014.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}